Article
Connecting cancer biology and clinical outcomes to imaging in KRAS mutant and wild-type colorectal cancer liver tumors following selective internal radiation therapy with yttrium-90.
Abdominal radiology (New York) - 1 Feb 2017
Magnetta Michael J, Ghodadra Anish, Lahti Steven J, Xing Minzhi, Zhang Di, Kim Hyun S
Abstract excerpt
PURPOSE: To determine whether pathologic colorectal tumor KRAS mutation status is correlated with progression-free survival (PFS) by imaging after selective internal radiation therapy with Yttrium-90 (SIRT Y90) for metastatic colorectal cancer in the liver (mCRC). MATERIALS AND METHODS: This was an IRB approved, HIPAA compliant retrospective cohort study. Consecutive patients with unresectable mCRC with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.